Healthcare provider profile · identity verified

Jerome B. Deck, MD

Internal Medicine · PLEASANTON, CA · NPI 1073691168

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	584	212
Amlodipine Besylate	Amlodipine Besylate	427	157
Levothyroxine Sodium	Levothyroxine Sodium	292	86
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	284	49
Lisinopril	Lisinopril	275	92
Atenolol	Atenolol	255	80
Losartan Potassium	Losartan Potassium	211	83
Gabapentin	Gabapentin	206	58
Famotidine	Famotidine	174	67
Hydrochlorothiazide	Hydrochlorothiazide	168	61
Lorazepam	Lorazepam	168	36
Fluticasone Propionate	Fluticasone Propionate	165	57
Tamsulosin Hcl	Tamsulosin Hcl	155	54
Albuterol Sulfate Hfa	Albuterol Sulfate	133	63
Trazodone Hcl	Trazodone Hcl	131	45
Furosemide	Furosemide	130	49
Simvastatin	Simvastatin	123	40
Omeprazole	Omeprazole	121	38
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	117	45
Metoprolol Tartrate	Metoprolol Tartrate	113	41
Pantoprazole Sodium	Pantoprazole Sodium	92	37
Potassium Chloride	Potassium Chloride	90	32
Metformin Hcl Er	Metformin Hcl	83	31
Ibuprofen	Ibuprofen	77	21
Tizanidine Hcl	Tizanidine Hcl	75	35
Citalopram Hbr	Citalopram Hydrobromide	74	24
Pravastatin Sodium	Pravastatin Sodium	74	27
Allopurinol	Allopurinol	73	24
Pradaxa	Dabigatran Etexilate Mesylate	72	28
Metoprolol Succinate	Metoprolol Succinate	71	19
Oxycodone Hcl	Oxycodone Hcl	69	suppressed
Alvesco	Ciclesonide	66	28
Fluoxetine Hcl	Fluoxetine Hcl	60	22
Glipizide	Glipizide	60	24
Wixela Inhub	Fluticasone Propion/Salmeterol	60	20
Alendronate Sodium	Alendronate Sodium	59	22
Lovastatin	Lovastatin	59	20
Triamcinolone Acetonide	Triamcinolone Acetonide	59	34
Colchicine	Colchicine	58	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	55	20
Tramadol Hcl	Tramadol Hcl	55	16
Sertraline Hcl	Sertraline Hcl	54	21
Nifedipine Er	Nifedipine	49	16
Terazosin Hcl	Terazosin Hcl	49	17
Hydralazine Hcl	Hydralazine Hcl	48	16
Metformin Hcl	Metformin Hcl	46	24
Prednisone	Prednisone	44	38
Fluocinonide	Fluocinonide	41	23
Meloxicam	Meloxicam	40	15
Ozempic	Semaglutide	39	suppressed
Acyclovir	Acyclovir	37	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	12
Montelukast Sodium	Montelukast Sodium	34	12
Rosuvastatin Calcium	Rosuvastatin Calcium	34	13
Finasteride	Finasteride	29	suppressed
Spiriva Respimat	Tiotropium Bromide	29	suppressed
Carvedilol	Carvedilol	27	13
Duloxetine Hcl	Duloxetine Hcl	26	13
Amoxicillin	Amoxicillin	24	24
Azithromycin	Azithromycin	24	23
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	11
Trospium Chloride	Trospium Chloride	23	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	23	suppressed
Cefadroxil	Cefadroxil	21	12
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	21	suppressed
Fluconazole	Fluconazole	21	11
Lidocaine	Lidocaine	21	suppressed
Methocarbamol	Methocarbamol	21	suppressed
Humulin N	Insulin Nph Human Isophane	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Jardiance	Empagliflozin	19	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	18	16
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Morphine Sulfate Er	Morphine Sulfate	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	16	16
Bupropion Xl	Bupropion Hcl	16	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	16	14
Clindamycin Hcl	Clindamycin Hcl	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Breyna	Budesonide/Formoterol Fumarate	15	suppressed
Cephalexin	Cephalexin	15	12
Levetiracetam	Levetiracetam	15	suppressed
Mupirocin	Mupirocin	15	12
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Retin-A	Tretinoin	15	suppressed
Salsalate	Salsalate	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Baclofen	Baclofen	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error